![]() Avedro Avedro is a medical device and pharmaceutical company that produces and delivers drugs and devices for corneal remodeling to eye care professionals. | ||
Founding Date | Founding Date 2002 | Founding Date 2000 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 122 | Employees 2048% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $27.7m (FY, 2018) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $10.9m (FY, 2018) | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $16.8m (FY, 2018) | Gross profit $71m (FY, 2024) |
Net income | Net income ($25.1m) (FY, 2018) | Net income ($21.5m) (FY, 2024) |
Operating ⚠ | ||
Patents (US) | Patents (US) 15 (Mar, 2019) | Patents (US) 43 (Jun, 2017) |
Trademarks (US) | Trademarks (US) 10 (Mar, 2019) | Trademarks (US) 3 (Jun, 2017) |
Funding | ||
Total funding raised | Total funding raised $ 67.6m | Total funding raised $ 120.5m |

OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company